Insights from 2023 ESMO Annual Meeting
M

ESMO 2023 Insights: "Phase 3 RUBY Trial - Dostarlimab + Chemotherapy for the Treatment of Primary Advanced or Recurrent Endometrial Cancer - Analysis of PFS & OS Outcomes by Molecular Classification"

By Insights from 2023 ESMO Annual Meeting FEATURING Mansoor Raza Mirza
By Insights from 2023 ESMO Annual Meeting FEATURING Mansoor Raza Mirza
328 views
October 26, 2023
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
06:07
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "Key Updates in Gynecological Cancers"

Feat. M. Raza Mirza
17:50
AdventHealth

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

Feat. G. Sonpavde
15:14
Brian Slomovitz

Update in Vulvar and Vaginal Cancer

08:45
Total Health

Recent Highlights in Endometrial Cancer

Feat. B. Slomovitz
08:16
Insights from 2024 SGO Annual Meeting

SGO 2024 Insights: "GOG-0258 - OS by Molecular Classification W…

Feat. A. Clements
10:35
UCLA Health

Updates in Endometrial Cancer

Feat. R. Salani
16:37
Total Health

2024 Updates in Uterine/Endometrial Cancer

Feat. T. Tillmanns
07:24
Fengting Yan

Year in Review: Endometrial Cancer

44:59
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

Updates on Cervical and Endometrial Cancers

Feat. K. Pennington
11:19
Insights from 2024 SGO Annual Meeting

SGO 2024 Insights: "RUBY Part 1 & Part 2 Trial - Dostarlima…

Feat. M. Raza Mirza
07:25
Insights from 2024 SGO Annual Meeting

SGO 2024 Insights: "The Use of Rucaparib vs. Placebo Maintenanc…

Feat. B. Corr
27:12
OncoAlert

New Endometrial Cancer FIGO Staging System in the Era of Molecular C…

Feat. N. Concin
18:46
OncoAlert

Systemic Therapies for Uterine Leiomyosarcoma

Feat. I. Ray-Coquard
14:09
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Phase 3 DUO-E/GOG-3041/ENGOT-EN10 Trial - …

Feat. S. Westin
12:55
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2024

Integrating Immunotherapy Into the Treatment of Endometrial Cancer

Feat. A. Wright
05:32
Insights from 2023 ESMO Asia Annual Meeting

LARA Trial: Preliminary Efficacy of Pembro + Lenvatinib in Recurrent…

Feat. N. Ngoi
10:27
Robert McBane

2023 ISTH Insights: "The EVE Trial - Extending VTE Secondary Pr…

16:40
Insights from 2023 ESGO Annual Meeting

ESGO 2023 Insights: "Latest Clinical Trial Updates That Have Ch…

Feat. C. Marth
10:43
Insights from 2023 ESGO Annual Meeting

ESGO 2023 Insights: "Are We Changing the History of Endometrial…

Feat. M. Raza Mirza
12:21
Insights from 2024 ESGO Annual Meeting

ESGO 2024 Insights: "PARP Inhibitor Resistance Mechanisms in Gy…

Feat. V. Heinzelmann-Schwarz